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Abstract
Objectives: Alzheimer’s disease (AD), an overwhelm-
ing neurodegenerative disease, has deleterious effects 
on the brain that consequently causes memory loss and 
language impairment. This study was intended to inves-
tigate the neuroprotective activity of the two essential 
oils (EOs) from Iranian Pistacia khinjuk (PK) leaves and 
Allium sativum (AS) cloves against β-Amyloid 25–35 
(Aβ25-35) induced elevation of cholinesterase enzymes 
in AD. 
Methods:  The EOs of PK (PKEO) and AS (ASEO) were 
prepared and analyzed in terms of extraction yield, phe-
nolic content, and cholinergic markers in vitro. Moreo-
ver, both were administered orally to adult male Wistar 
rats at concentrations of 1, 2, and 3%. The inhibitory po-
tential of PKEO and ASEO was compared with Donepe-
zil (0.75 mg/kg) against the high activities of acetylcho-
linesterase (AChE) and butyrylcholinesterase (BChE) 
enzymes.
Results: PKEO reached an inhibition rate of 83.6% and 
81.4% against AChE and BChE, respectively. ASEO had 
lower anti-cholinesterase activity (65.4% and 31.5% for 
the inhibition AChE and BChE). PKEO was found to 
have more phenolic content than ASEO. A significant-
ly positive correlation was observed between the total 
phenolics and anti-cholinesterase potential. In rats, 
both EOs decreased the enzyme activity in a concen-
tration-dependent manner. As compared with Done-
pezil, the significant difference in the AChE and BChE 
inhibition occurred as rats were treated with PKEO 3% 
(p < 0.05). 
Conclusion: It could be concluded that PKEO and 
ASEO are potent inhibitors of AChE and BChE in rats 
that hold promise to be used for the treatment of AD. 
1.Introduction
Alzheimer's disease (AD), a chronic and progres-
sive degenerative disease, is considered as one of the 
most common causes of dementia in elderly [1]. Bar-
tus et al. suggested that the cholinergic dysfunction 
in the brain of healthy elderly and dementia people 
can cause the memory loss and subsequent cognitive 
damage, thus, the repair of cholinergic activity prob-
ably decreases the serious lack of cognitive function 
[2]. Acetylcholine (ACh) is a critical neurotransmitter 
used by cholinergic neurons in main physiological 
processes, including attention, learning, memory, and 
so forth [3]. The presence of impairment to the cholin-
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